Biblio
“Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.”, J Alzheimers Dis, vol. 80, no. 1, pp. 209-223, 2021.
, “Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 107-118, 2017.
, “Risk of dementia in patients with celiac disease: a population-based cohort study.”, J Alzheimers Dis, vol. 49, no. 1, pp. 179-85, 2016.
, “Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 367-380, 2022.
, “Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.”, J Alzheimers Dis, vol. 62, no. 1, pp. 227-238, 2018.
, “Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging.”, J Alzheimers Dis, vol. 66, no. 2, pp. 733-741, 2018.
, “Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
, “Risk Factors of Rapid Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 66, no. 2, pp. 497-515, 2018.
, “Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 483-493, 2017.
, “Risk Factors for Mild Cognitive Impairment in German Primary Care Practices.”, J Alzheimers Dis, vol. 56, no. 1, pp. 379-384, 2017.
, “Risk Factors for Longer-Term Mortality in Discharged Patients with Dementia and SARS-CoV-2 Infection: A Matched Case-Control Study.”, J Alzheimers Dis, vol. 92, no. 1, pp. 295-309, 2023.
, “Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population.”, J Alzheimers Dis, vol. 67, no. 4, pp. 1209-1219, 2019.
, “Risk Factors Associated with Cortical Thickness and White Matter Hyperintensities in Dementia Free Okinawan Elderly.”, J Alzheimers Dis, vol. 63, no. 1, pp. 365-372, 2018.
, “Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1519-1528, 2017.
, “Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1335-42, 2016.
, “The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.
, “The Rhythmicity of Clock Genes is Disrupted in the Choroid Plexus of the APP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 2, pp. 795-806, 2020.
, “Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
, “Rheumatoid Arthritis and Cognitive Impairment or Dementia: An Updated Review of Epidemiological Data.”, J Alzheimers Dis, vol. 95, no. 3, pp. 769-783, 2023.
, “Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 209-222, 2017.
, “Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.”, J Alzheimers Dis, vol. 64, no. s1, pp. S47-S105, 2018.
, “Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings.”, J Alzheimers Dis, vol. 50, no. 2, pp. 465-76, 2016.
, “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
, “A Review of the Familial Alzheimer's Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1323-1339, 2018.
, “Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 753-71, 2016.
,